Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
530207 BRAWN

Brawn Biotech Share Price

 

 

Brawn Biotech live price: ₹20.55. It opened at ₹21 vs previous close ₹22; intraday high/low: ₹21/₹21. The 50 & 200 DMA stand at ₹20.69/₹20.34.

Brawn Biotech Performance

  • Today's Low
  • ₹21
  • Today's High
  • ₹21
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹24
  • Open Price₹21
  • Previous Close₹22
  • Volume333
  • 50 DMA₹20.69
  • 100 DMA₹20.59
  • 200 DMA₹20.34

Brawn Biotech Chart

Investment Returns

  • Over 1 Month -8.26%
  • Over 3 Month + 9.66%
  • Over 6 Month -1.2%
  • Over 1 Year + 27.09%

Smart Investing Starts Here Start SIP with Brawn Biotech for Steady Growth!

Invest Now

Brawn Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -44.9
  • PEG Ratio
  • -0.5
  • Market Cap Cr
  • 6
  • P/B Ratio
  • 1.6
  • Average True Range
  • 0.76
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.17
  • RSI
  • 56.55
  • MFI
  • 36.69

Brawn Biotech Financials

Brawn Biotech Technicals

EMA & SMA

Current Price
₹20.55
-1.05 (-4.86%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹20.91
  • 50 Day
  • ₹20.69
  • 100 Day
  • ₹20.59
  • 200 Day
  • ₹20.34

Resistance and Support

21.6 Pivot Speed
  • R3 21.60
  • R2 21.60
  • R1 21.60
  • S1 21.60
  • S2 21.60
  • S3 21.60

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Brawn Biotech has an operating revenue of Rs. 17.26 Cr. on a trailing 12-month basis. An annual revenue de-growth of -18% needs improvement, Pre-tax margin of -13% needs improvement, ROE of -51% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 65 which is a FAIR score but needs to improve its earnings, a RS Rating of 82 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Brawn Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-05-26 Audited Results
2025-02-12 Quarterly Results
2024-11-14 Quarterly Results

Brawn Biotech Shareholding Pattern

52.94%
0.35%
0%
0%
0%
30.49%
16.22%

Brawn Biotech FAQs

Brawn Biotech share price is ₹20 As on 22 May, 2026 | 16:58

The Market Cap of Brawn Biotech is ₹6.2 Cr As on 22 May, 2026 | 16:58

The P/E ratio of Brawn Biotech is -44.9 As on 22 May, 2026 | 16:58

The PB ratio of Brawn Biotech is 1.6 As on 22 May, 2026 | 16:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23